(Press-News.org) ANN ARBOR—In work that unmasks some of the magic behind memristors and "resistive random access memory," or RRAM—cutting-edge computer components that combine logic and memory functions—researchers have shown that the metal particles in memristors don't stay put as previously thought.
The findings have broad implications for the semiconductor industry and beyond. They show, for the first time, exactly how some memristors remember.
"Most people have thought you can't move metal particles in a solid material," said Wei Lu, associate professor of electrical and computer engineering at the University of Michigan. "In a liquid and gas, it's mobile and people understand that, but in a solid we don't expect this behavior. This is the first time it has been shown."
The results could lead to a new approach to chip design—one that involves using fine-tuned electrical signals to lay out integrated circuits after they're fabricated. And it could also advance memristor technology, which promises smaller, faster, cheaper chips and computers inspired by biological brains in that they could perform many tasks at the same time.
Lu, who led the project, and colleagues at U-M and the Electronic Research Centre Jülich in Germany used transmission electron microscopes to watch and record what happens to the atoms in the metal layer of their memristor when they exposed it to an electric field. The metal layer was encased in the dielectric material silicon dioxide, which is commonly used in the semiconductor industry to help route electricity.
They observed the metal atoms becoming charged ions, clustering with up to thousands of others into metal nanoparticles, and then migrating and forming a bridge between the electrodes at the opposite ends of the dielectric material.
They demonstrated this process with several metals, including silver and platinum. And depending on the materials involved and the electric current, the bridge formed in different ways.
The bridge, also called a conducting filament, stays put after the electrical power is turned off in the device. So when researchers turn the power back on, the bridge is there as a smooth pathway for current to travel along. Further, the electric field can be used to change the shape and size of the filament, or break the filament altogether, which in turn regulates the resistance of the device, or how easy current can flow through it.
Computers built with memristors would encode information in these different resistance values, which is in turn based on a different arrangement of conducting filaments.
Memristor researchers like Lu and his colleagues had theorized that the metal atoms in memristors moved, but previous results had yielded different shaped filaments and so they thought they hadn't nailed down the underlying process.
"We succeeded in resolving the puzzle of apparently contradicting observations and in offering a predictive model accounting for materials and conditions," said Ilia Valov, principle investigator at the Electronic Materials Research Centre Jülich. "Also the fact that we observed particle movement driven by electrochemical forces within dielectric matrix is in itself a sensation."
INFORMATION:
Lu is a co-founder of Crossbar Inc., a Santa Clara, Calif.-based startup working to commercialize RRAM. Crossbar has just completed a $25 million Series C funding round.
The study is titled "Electrochemical dynamics of nanoscale metallic inclusions in dielectrics." It is newly published online in Nature Communications. The work was funded by the Air Force Office of Scientific Research, the U.S. Department of Energy and the National Science Foundation and the German Research Foundation priority program SFB 917.
Study abstract: http://bit.ly/1wsxgPz
Wei Lu: http://web.eecs.umich.edu/~wluee
Metal particles in solids aren't as fixed as they seem, new memristor study shows
2014-06-24
ELSE PRESS RELEASES FROM THIS DATE:
Researchers at Intermountain Medical Center develop new smartphone technology and app to diagnose and monitor adrenal gland diseases
2014-06-24
Diseases of the adrenal gland have long been difficult to diagnose. But now, researchers have found an affordable and easy way to diagnose and monitor endocrine diseases of the adrenal gland by using saliva and a smartphone.
Researchers at Intermountain Medical Center in Murray, Utah, have developed new smartphone technology to help screen patients for a number of adrenal gland diseases, including Cushing's syndrome. The new tool also helps to identify adrenal insufficiency, monitor cortisol replacement and assess physiologic changes in adrenal function.
Adrenal diseases ...
To advance care for patients with brain metastases: Reject five myths
2014-06-24
New York, NY – A blue-ribbon team of national experts on brain cancer says that professional pessimism and out-of-date "myths," rather than current science, are guiding -- and compromising -- the care of patients with cancers that spread to the brain.
In a special article published in the July issue of Neurosurgery, the team, led by an NYU Langone Medical Center neurosurgeon, argues that many past, key clinical trials were designed with out-of-date assumptions and the tendency of some physicians to "lump together" brain metastases of diverse kinds of cancer, often results ...
Mayo Clinic researchers say gene in brain linked to kidney cancer
2014-06-24
JACKSONVILLE, Fla. — A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Their study, published in Cancer Research, reveals that the gene NPTX2, plays an essential role in this cancer type, which is resistant to common chemotherapy and has a five-year overall survival rate of less than 10 percent in patients with metastatic disease.
MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic ...
Virus kills triple negative breast cancer cells, tumor cells in mice
2014-06-24
A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer.
Adeno-associated virus type 2 (AAV2) infects humans but is not known to cause sickness. In prior studies, the researchers tested the virus on a variety of breast cancers that represent degrees of aggressiveness and on human papillomavirus-positive cervical cancer cells. The virus initiated apoptosis -- ...
Morphable surfaces could cut air resistance
2014-06-24
CAMBRIDGE, Mass-- There is a story about how the modern golf ball, with its dimpled surface, came to be: In the mid-1800s, it is said, new golf balls were smooth, but became dimpled over time as impacts left permanent dents. Smooth new balls were typically used for tournament play, but in one match, a player ran short, had to use an old, dented one, and realized that he could drive this dimpled ball much further than a smooth one.
Whether that story is true or not, testing over the years has proved that a golf ball's irregular surface really does dramatically increase ...
CNIO researcher Ana Losada revises the role of cohesin in cancer
2014-06-24
Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation. A good example of this is cohesin, a ring-shaped protein complex that embraces DNA to control cell division. Just a few months ago, and after several studies in the same direction, the sequencing of thousands of tumour samples identified the STAG2 gene—whose product forms part of cohesin—as one of the most frequently mutated genes in several types of cancer such as bladder cancer and melanoma.
The challenge now is to understand the link between ...
Quick, easy, inexpensive cortisol testing should soon be available on all smartphones
2014-06-24
CHICAGO, IL—Researchers have developed a device that uses any smartphone to measure the cortisol concentration in saliva. The device was presented Tuesday, June 24, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago.
"We have developed a method for measuring cortisol in saliva using a smartphone and a disposable test strip. This innovation enables anyone with a smartphone to measure their salivary cortisol level quickly, accurately, and affordably," said lead study author Joel R. L. Ehrenkranz, MD, director ...
Sweet sweet straw
2014-06-24
This news release is available in German. Erythritol has many great advantages: it does not make you fat, it does not cause tooth decay, it has no effect on the blood sugar and, unlike other sweeteners, it does not have a laxative effect. In Asia it is already widely used and it is becoming more and more common in other parts of the world too. Up until now, erythritol could only be produced with the help of special kinds of yeast in highly concentrated molasses. At the TU Vienna, a method has now been developed to produce the sweetener from ordinary straw with the help ...
Expert outlines challenges of visual accessibility for people with low vision
2014-06-24
June 24, 2014 – New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Vision science, in collaboration with other professions, has a key role in developing technologies and design approaches to promote visual accessibility for the millions of people living with low vision, according ...
Experts cite 'misconceptions' on brain metastases
2014-06-24
June 24, 2014 – "Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Dr. Douglas Kondziolka of NYU Langone Medical Center and coauthors identify some issues that may be standing in the way of optimal clinical management for patients with cancer that has spread to the brain from other ...